Samsung Biologics to acquire Switzerland's PolyPeptide Group in $1.8 billion all-cash deal ⊕
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Samsung Biologics acquires PolyPeptide Group for 2.7 trillion won ($1.8 billion)